September 12, 2025

Tyra Biosciences, Inc. (TYRA): Investor Outlook Reveals 152.61% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA) is gaining attention in the biotechnology sector as a key player in the development of precision medicines targeting fibroblast growth factor..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges with a Potential 8.56% Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is navigating a complex financial landscape with a market capitalization of $618.05 million...

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 70% Potential Upside in the Rare Disease Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing the attention of investors with a compelling narrative in the healthcare sector, particularly within the niche of drug manufacturers..

Weave Communications, Inc. (WEAV) Stock Analysis: Insights into a High-Growth Healthcare Tech Player with 52.87% Upside Potential

Weave Communications, Inc. (NASDAQ: WEAV), a key player in the Health Information Services industry, is making waves with its innovative customer experience and payments software platform..

Akso Health Group (AHG) Investor Outlook: A Closer Look at This Chinese Healthcare Disruptor with Eye-Catching Revenue Growth

Akso Health Group (NASDAQ: AHG), a burgeoning entity within the healthcare sector, has been turning heads with its impressive revenue growth, which has skyrocketed by 415.80%...

AxoGen, Inc. (AXGN) Stock Analysis: 47% Potential Upside Beckons Investors

AxoGen, Inc. (NASDAQ: AXGN), a notable player in the healthcare sector specializing in medical devices, is capturing investor attention with its promising outlook and innovative approach..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Exploring a Potential 147% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is capturing investor attention with its promising potential in the healthcare sector, particularly in the niche of kidney disease therapeutics. With..

uniQure N.V. (QURE) Stock Analysis: Biotechnology Innovator with a Potential 119% Upside

uniQure N.V. (NASDAQ: QURE), a Netherlands-based biotechnology company, is capturing investor attention with its pioneering work in gene therapy. With a market capitalization of $929.45 million,..

Pharvaris N.V. (PHVS) Stock Analysis: Evaluating a 44% Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a biopharmaceutical innovator based in Switzerland, is drawing considerable attention from investors in the biotechnology sector. With a market capitalization of $1.51 billion,..

Claritev Corporation (CTEV) Investor Outlook: Navigating Healthcare Analytics with a 14.37% Potential Upside

Investors eyeing the healthcare sector might find Claritev Corporation (NASDAQ: CTEV) an intriguing opportunity, especially with its significant potential upside of 14.37% based on current analyst..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Potential 229% Upside Amidst Biotech Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, is currently navigating a challenging landscape with a substantial promise for future growth. This..

Capricor Therapeutics, Inc. (CAPR): A Biotechnology Stock with 219.88% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is capturing investor attention with its potential upside of 219.88% based on current analyst ratings. As a..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 76% Potential Upside with Strong Buy Ratings

Simulations Plus, Inc. (NASDAQ: SLP), a key player in the healthcare sector, specializes in health information services. With a market cap of approximately $289 million, the..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A Closer Look at Its 6.63% Potential Upside

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been capturing investor attention within the biotechnology sector, with its focus on pioneering treatments for neurodegenerative diseases and endocrine conditions...

Geron Corporation (GERN) Stock Analysis: Unveiling a 174% Upside Potential in the Biotech Sector

Geron Corporation (NASDAQ: GERN) is capturing the attention of investors with its promising growth potential in the biotechnology sector. Known for its innovative approach to oncology..

Taysha Gene Therapies (TSHA) Stock Analysis: Unraveling the 167% Upside Potential

Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its ambitious focus on developing adeno-associated virus-based gene therapies aimed at treating monogenic..

Talkspace, Inc. (TALK) Stock Analysis: A Healthcare Innovator with an 84.62% Upside Potential

Talkspace, Inc. (NASDAQ: TALK), a burgeoning player in the healthcare sector, is captivating the attention of investors with its innovative approach to mental health services and..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a 13.86% Upside Potential Amidst Healthcare Innovation

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector under the Diagnostics & Research industry, is capturing investor attention with its potential upside..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unveiling a Potential 229% Upside in the Biotech Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology industry, is capturing attention with its impressive potential upside of 229.04%, according to analyst..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Challenges with Growth in Animal Health Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a notable player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic..

Search

Funds

September 12, 2025

Search

Funds

September 12, 2025

FTSE 100

Funds